PRK Partners is a leading regional full-service law firm with a team of experienced legal and tax professionals and close to thirty years’ experience in providing outstanding service in Central Europe. The firm has worked on many of the region’s largest and most complex transactions. With offices and teams in both Slovakia and the Czech Republic, PRK is perfectly suited for cross-border matters between these two countries. PRK combines profound knowledge of the local legal system with an international perspective. The firm frequently works on a non-exclusive basis with leading international law firms on large cross-border transactions.
PRK’s team is led by highly experienced and internationally educated partners. The team includes eminent academics who have co-authored key legislation in Slovakia and the Czech Republic.
PRK is consistently recognised among the top law firms by leading international and domestic directories and rating agencies and has been honoured with numerous awards, repeatedly Best Law Firm of the Year (national competitions organized by epravo.sk), Law Firm of the Year 2016 by Chambers & Partners, Law Firm of the Year 2012 for the Central European Region (and consistently ranked among the top 6 finalists every year) by top UK legal magazine, The Lawyer.
The firm has a strong commitment to corporate social responsibility and pro bono work.
PRK Partners is a member of Lex Mundi (exclusive member for the Czech Republic) and Celia Alliance.
The legal framework for orphan drugs and rare diseases in the Slovakian Pharma. Prepared in association with PRK Partners, a leading global law firm, this is an extract from The Pharma Legal Handbook: Slovakia, available to purchase here for GBP 75. 1. What is the definition of Rare Diseases in your country? The Slovak legislation does not have a specific legal definition for Rare Diseases. The Slovak Act on Medicinal Products rather refers to the Regulation (EC) No. 141/2000 with respect…
The legal framework for biosimilars and biologics in Slovakian Pharma. Prepared in association with PRK Partners, a leading global law firm, this is an extract from The Pharma Legal Handbook: Slovakia, available to purchase here for GBP 75. 1. Are biosimilar medicines considered the same as generic medicines in your country? Biosimilar medicines are not considered the same as generic medicines in Slovakia. A similar biological medicinal product, also known as “biosimilar”, is a product which is similar (not identical)…
The legal framework for localization in Slovakian Pharma. Prepared in association with PRK Partners, a leading global law firm, this is an extract from The Pharma Legal Handbook: Slovakia, available to purchase here for GBP 75. 1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? There are generally not such rules. However, the handling with medicinal products (as defined by the Act on Medicinal…